Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,530.00
-10.00 (-0.28%)
At close: Jun 10, 2026

Meta Biomed Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
16,92817,95614,51710,79613,22610,113
Short-Term Investments
89.152,97313,0002,9704,4101,957
Trading Asset Securities
20,73216,93426,7813,0441,5053,846
Cash & Short-Term Investments
37,74937,86354,29816,81019,14115,916
Cash Growth
-25.98%-30.27%223.01%-12.18%20.26%-24.37%
Accounts Receivable
20,34317,96613,38112,88012,82212,409
Other Receivables
1,1991,8891,3791,6521,682636.92
Receivables
21,57319,88617,26114,53214,50413,046
Inventory
23,98023,27918,77515,40214,73415,276
Prepaid Expenses
-971.751,6781,9541,158100.45
Other Current Assets
1,382813.681,9451,2271,4391,322
Total Current Assets
84,68482,81493,95749,92450,97645,661
Property, Plant & Equipment
79,64276,90464,09959,08652,12339,278
Long-Term Investments
13,91313,2276,2327,1187,6877,365
Goodwill
-1,1071,0081,0082,023524.06
Other Intangible Assets
2,055955.44824.26675.57688.41783.26
Long-Term Deferred Tax Assets
5,9115,8026,1517,0804,7834,966
Long-Term Deferred Charges
-----70.9
Other Long-Term Assets
1,6203,7953,9661,804879.893,627
Total Assets
189,824186,604177,295130,124121,072103,128
Accounts Payable
2,4722,4712,6732,9232,4251,922
Accrued Expenses
1,6782,1441,4031,303910.411,121
Short-Term Debt
37,74937,36749,35330,97131,23024,830
Current Portion of Long-Term Debt
23.133,931299.33728.19948.685,532
Current Portion of Leases
480.24479.46435.83246.82145.81187.8
Current Income Taxes Payable
505.09724.38261.836.7510.142.1
Other Current Liabilities
11,79612,51319,1718,2939,1474,527
Total Current Liabilities
54,70559,63173,59744,47144,81738,161
Long-Term Debt
5,748735.85,60012,20711,6183,842
Long-Term Leases
235.06206.52434.4294.66128.7687.6
Pension & Post-Retirement Benefits
-00-00195.65
Long-Term Deferred Tax Liabilities
-----192.08
Other Long-Term Liabilities
1,1851,1571,553489.031,069551.35
Total Liabilities
61,87261,73081,18557,46257,63343,030
Common Stock
14,04714,04711,93111,93111,93111,931
Additional Paid-In Capital
55,43955,22234,66634,66634,45534,455
Retained Earnings
56,44357,43147,12725,35915,81013,640
Treasury Stock
--2,982-2,982-2,842-2,842-2,778
Comprehensive Income & Other
1,595598.582,597933.391,2371,075
Total Common Equity
127,524124,31693,33970,04860,59158,323
Minority Interest
428.2557.032,7712,6142,8481,775
Shareholders' Equity
127,952124,87396,11072,66263,43960,099
Total Liabilities & Equity
189,824186,604177,295130,124121,072103,128
Total Debt
44,23542,72056,12344,44844,07234,478
Net Cash (Debt)
-6,487-4,857-1,824-27,638-24,931-18,562
Net Cash Per Share
-248.74-193.45-67.29-1208.43-1089.37-810.54
Filing Date Shares Outstanding
27.0827.0622.8322.8722.8722.9
Total Common Shares Outstanding
27.0827.0622.8322.8722.8722.9
Working Capital
29,97923,18320,3605,4526,1587,499
Book Value Per Share
4709.014593.594088.233062.712649.242546.74
Tangible Book Value
125,469122,25491,50668,36457,87957,016
Tangible Book Value Per Share
4633.144517.384007.952989.082530.672489.66
Land
-9,1488,8936,1246,7686,727
Buildings
-45,83335,70434,81721,32220,924
Machinery
-54,73948,84247,58738,73734,361
Construction In Progress
-1,2451,4651,17811,993297.15